Skip to main content
SpringerLink
Log in

The prognostic value of prostate-specific antigen and prostatic acid phosphatase in serum of patients with prostate cancer after orchidectomy

  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Correlations between the serum levels of PAP and PSA before and 1, 3 and 6 months after orchidecomy in 27 prostatic cancer patients (advanced clinical stages C and D according to Whitemore scale) were studied. The PSA values correlated more distinctly than PAP with the general clinical condition. PSA is a reliable tumour marker when used at regular intervals, especially for monitoring therapeutic results. A high preoperative PSA level correlates with a high postoperative level and progression of the disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Dutkiewicz, S.: Hormonal treatment of prostatic carcinoma.Therapy and Medicaments, 39, 29 (1989).

    Google Scholar 

  2. Fitzpatrick, J. M., Krane, R. J. (eds): The Prostate. Churchill-Livingstone, Edinburgh 1989.

    Google Scholar 

  3. Habib, F. K., Odoma, S., Busuttil, A., Chisholm, G. D.: Androgen receptors in cancer of the prostate. Correlation with the stage and grade of the tumor.Cancer, 57, 2351 (1986).

    Article  PubMed  CAS  Google Scholar 

  4. Heller, J. E.: Prostatic acid phosphatase: Its current clinical status.J. Urol., 137, 1091 (1987).

    PubMed  CAS  Google Scholar 

  5. Kernion, J. B. (ed.): Immunotherapy of Urological Tumours. Churchill-Livingstone, Edinburgh 1990.

    Google Scholar 

  6. Murphy, G. P., Khoury, S., Kuss, R., Chatelain, Ch., Denis, L. (eds): Prostate Cancer. Part A.: Research, Endocrine Treatment and Histopathology. Alan R. Liss, Inc. New York 1987.

    Google Scholar 

  7. Silverberg, E., Lubera, J.: Cancer statistics 1989.Cancer J. Clin., 39, 3 (1989).

    CAS  Google Scholar 

  8. Smith, J. A. Jr.: New methods of endocrine management of prostatic cancer.J. Urol., 137, 1 (1987).

    PubMed  CAS  Google Scholar 

  9. Stamey, T. A.: Die Rolle des prostataspezifischen Antigens bei der Diagnose und Behandlung des Prostataadenokarzinoms.Urologe, 29, 52 (1990).

    PubMed  CAS  Google Scholar 

  10. Stamey, T. A., Yang, N., Hay, A. R., McNeal, J. E., Freiha, F. S., Redwine, E.: Prostate specific antigen as a serum marker for adenocarcinoma of the prostate.N. Engl. J. Med., 317, 909 (1987).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Urology, Institute of Clinical Medicine M.I.A., Warsaw, Poland

    S. Dutkiewicz

  2. Department of Clinical Urology, Central Clinical Hospital M.M.A., Warsaw, Poland

    B. Stawarz & H. Zieliński

  3. Department of Nuclear Medicine, C.C.H. M.M.A., Warsaw, Poland

    A. Łypka

Authors
  1. S. Dutkiewicz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B. Stawarz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Łypka
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. H. Zieliński
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dutkiewicz, S., Stawarz, B., Łypka, A. et al. The prognostic value of prostate-specific antigen and prostatic acid phosphatase in serum of patients with prostate cancer after orchidectomy. International Urology and Nephrology 24, 409–416 (1992). https://doi.org/10.1007/BF02550635

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02550635

Keywords

Search

Navigation